Suchergebnisse - (Person:"Adhikari, Nilanjan")

PubPharm (10)

1

Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer

enthalten in: European journal of medicinal chemistry | 2022

von Pulya, S. | Patel, T. | Paul, M. | +6

2

Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model

enthalten in: Bioorganic chemistry | 2021

von Routholla, G. | Pulya, S. | Patel, T. | +7

3

Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors

enthalten in: Bioorganic chemistry | 2021

von Routholla, G. | Pulya, S. | Patel, T. | +5

4

Dissecting Histone Deacetylase 3 in Multiple Disease Conditions : Selective Inhibition as a Promising Therapeutic Strategy

enthalten in: Journal of medicinal chemistry | 2021

von Adhikari, N. | Jha, T. | Ghosh, B.

5

Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents : A review

enthalten in: European journal of medicinal chemistry | 2020

von Sarkar, R. | Banerjee, S. | Amin, S. | +2

6

Design, synthesis, biological evaluation and molecular docking study of arylcarboxamido piperidine and piperazine-based hydroxamates as potential HDAC8 inhibitors with promising anticancer activity

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2019

von Trivedi, P. | Adhikari, N. | Amin, S. | +4

7

Designing potential HDAC3 inhibitors to improve memory and learning

enthalten in: Journal of biomolecular structure & dynamics | 2019

von Amin, S. | Adhikari, N. | Jha, T. | +1

8

Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides

enthalten in: European journal of medicinal chemistry | 2019

von Amin, S. | Adhikari, N. | Kotagiri, S. | +2

9

Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2018

von Trivedi, P. | Adhikari, N. | Amin, S. | +2

10

HDAC3 is a potential validated target for cancer : An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches

enthalten in: European journal of medicinal chemistry | 2018

von Adhikari, N. | Amin, S. | Trivedi, P. | +2

1
[1]